BackgroundCheck.run
Search For

Elizabeth C Nowak, 44West Lebanon, NH

Related to:
Rita L Cate 89 Elizabeth Cate 79

Elizabeth Nowak Phones & Addresses

West Lebanon, NH   

95 Ashland St, Manchester, NH 03104   

891 West St, Hartford, CT 06105   

Rochester, NY   

Work

Company: McCarthy, Lebit, Crystal & Liffman Co., L.P.A. Address:
Get Report
Control this profile

Mentions for Elizabeth C Nowak

Career records & work history

Lawyers & Attorneys

Elizabeth Nowak Photo 1

Elizabeth Nowak - Lawyer

Office:
McCarthy, Lebit, Crystal & Liffman Co., L.P.A.
Specialties:
Business, Real Estate, Corporate Law, Commercial Banking
ISLN:
918981439
Admitted:
2005
University:
Ohio University, B.A., 2002
Law School:
Case Western Reserve, J.D., 2005

Medicine Doctors

Elizabeth A. Nowak

Specialties:
Internal Medicine - Geriatrics
Work:
Elder Service Plan
1135 Morton St, Mattapan, MA 02126
617-5332400 (phone) 617-5332471 (fax)
Education:
Medical School
SUNY Upstate Medical University
Graduated: 2005
Procedures:
Vaccine Administration
Languages:
English, Spanish
Description:
Dr. Nowak graduated from the SUNY Upstate Medical University in 2005. She works in Mattapan, MA and specializes in Internal Medicine - Geriatrics.

License Records

Elizabeth A Nowak

Licenses:
License #: 1081 - Active
Category: Veterinary Medicine
Issued Date: Sep 7, 1991
Expiration Date: Dec 31, 2017
Type: Veterinarian

Elizabeth Nowak resumes & CV records

Resumes

Elizabeth Nowak Photo 27

Post-Doctoral Fellow

Location:
Lebanon, NH
Industry:
Higher Education
Work:
Dartmouth College
Post-Doctoral Fellow
Elizabeth Nowak Photo 28

Elizabeth Nowak

Location:
United States
Elizabeth Nowak Photo 29

Elizabeth Nowak

Location:
United States
Elizabeth Nowak Photo 30

Elizabeth Nowak

Location:
United States

Publications & IP owners

Us Patents

Autoimmune Disorder Treatment Using Rxr Agonists

US Patent:
2013019, Jul 25, 2013
Filed:
Dec 13, 2012
Appl. No.:
13/714051
Inventors:
IO Therapeutics, Inc. - Laguna Hills CA, US
Dartmouth College - Hanover NH, US
Elizabeth Nowak - West Lebanon NH, US
Randolph Noelle - Plainfield NH, US
Assignee:
Dartmouth College - Hanover NH
IO Therapeutics, Inc. - Laguna Hills CA
International Classification:
A61K 31/192
US Classification:
514510, 514569
Abstract:
The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.

Vista-Ig For Treatment Of Autoimmune, Allergic And Inflammatory Disorders

US Patent:
2014005, Feb 27, 2014
Filed:
Jun 24, 2013
Appl. No.:
13/925094
Inventors:
- London, GB
Isabelle LeMercier - Enfield NH, US
Elizabeth Nowak - West Lebanon NH, US
Janet Lines - London, GB
International Classification:
C07K 16/18
A61K 38/21
A61K 39/395
US Classification:
4241341, 424 857, 424 856
Abstract:
The present invention relates to a fusion proteins comprising regulatory T cell protein, VISTA (V-domain Immunoglobulin Suppressor of T cell Activation (PD-L3) and an immunoglobulin protein (Ig). The invention also provides the use of VISTA polypeptides, multimeric VISTA polypeptides, VISTA-conjugates (e.g., VISTA-Ig), and VISTA antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions.

Inflammation And Autoimmune Disorder Treatment Using Rara Selective Agonists

US Patent:
2012023, Sep 20, 2012
Filed:
Mar 14, 2012
Appl. No.:
13/420067
Inventors:
Roshantha A. Chandraratna - Laguna Hills CA, US
Elizabeth Nowak - West Lebanon NH, US
Randolph Noelle - Plainfield NH, US
International Classification:
A61K 31/196
A61P 29/00
A61P 11/00
A61P 25/22
A61P 25/24
A61P 3/08
A61K 31/24
A61P 1/00
US Classification:
514510, 514563
Abstract:
The present specification provides compounds, compositions and methods using such compounds and compositions to treat an autoimmune disorder, inflammation and/or a transplant rejection.

Treatment Of Diseases By Concurrently Eliciting Remyelination Effects And Immunomodulatory Effects Using Selective Rxr Agonists

US Patent:
2022037, Nov 24, 2022
Filed:
Jul 7, 2022
Appl. No.:
17/859743
Inventors:
- Spring TX, US
- Hanover NH, US
Elizabeth Nowak - West Lebanon NH, US
Randolph Noelle - Plainfield NH, US
Martin E. Sanders - Spring TX, US
International Classification:
A61K 31/192
A61K 31/4704
A61K 31/343
A61K 31/47
A61K 31/353
A61K 31/216
Abstract:
The present specification provides RXR agonists with both remyelination promotion and immunomodulatory activities, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat a demyelination-related disorder by both promoting remyelination of neurons and modulating the immune system.

Vista Antagonist And Methods Of Use

US Patent:
2021036, Nov 25, 2021
Filed:
Feb 26, 2021
Appl. No.:
17/186199
Inventors:
- London, GB
- Hanover NH, US
Isabelle LEMERCIER - Enfield NH, US
Elizabeth NOWAK - West Lebanon NH, US
Janet LINES - London, GB
Li WANG - Norwich VT, US
Mark SPALLER - Lebanon NH, US
International Classification:
A61K 38/10
C07K 7/08
A61K 45/06
A61K 9/00
A61K 39/00
C07K 16/28
G01N 33/566
Abstract:
The present invention is directed to a peptide, multimer, conjugate, analog, derivative or mimetic thereof that inhibits the activity of VISTA. The invention further contemplates therapeutic use of the VISTA antagonist peptide, multimer, conjugate, derivative or mimetic thereof, including treating or preventing cancer, bacterial infections, viral infections, parasitic infections and fungal infections, as well as research uses of the antagonist.

Novel Vista-Ig Constructs And The Use Of Vista-Ig For Treatment Of Autoimmune, Allergic And Inflammatory Disorders

US Patent:
2021014, May 20, 2021
Filed:
Jul 30, 2020
Appl. No.:
16/943413
Inventors:
- Hanover NH, US
- London, GB
Isabelle LeMercier - Enfield NH, US
Elizabeth Nowak - West Lebanon NH, US
Janet Lines - London, GB
International Classification:
C07K 16/18
A61K 39/39
A61K 39/395
C07K 16/28
A01K 67/027
C07K 14/705
A61K 45/06
C12N 15/113
Abstract:
The present invention relates to a fusion proteins comprising regulatory T cell protein, VISTA (V-domain Immunoglobulin Suppressor of T cell Activation (PD-L3) and an immunoglobulin protein (Ig), preferably also containing a flexible linker intervening the VISTA and Ig Fc polypeptide. The invention also provides the use of VISTA polypeptides, multimeric VISTA polypeptides, VISTA-conjugates (e.g., VISTA-Ig), and VISTA antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions, especially lupus, multiple sclerosis, psoriasis, psoriatic arthritis, multiple sclerosis, Crohn's disease, inflammatory bowel disease and type 1 or type 2 diabetes.

Autoimmune Disorder Treatment Using Rxr Agonists

US Patent:
2021012, May 6, 2021
Filed:
Dec 18, 2020
Appl. No.:
17/126714
Inventors:
- Houston TX, US
- Hanover NH, US
Elizabeth Nowak - West Lebanon NH, US
Randolph Noelle - Plainfield NH, US
International Classification:
A61K 31/192
A61K 31/216
A61K 31/201
A61K 31/353
A61K 31/343
A61K 31/47
A61K 31/4704
A61K 9/00
Abstract:
The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.

Autoimmune Disorder Treatment Using Rxr Agonists

US Patent:
2021012, May 6, 2021
Filed:
Dec 18, 2020
Appl. No.:
17/126787
Inventors:
- Houston TX, US
- Hanover NH, US
Elizabeth Nowak - West Lebanon NH, US
Randolph Noelle - Plainfield NH, US
International Classification:
A61K 31/192
A61K 31/216
A61K 31/201
A61K 31/353
A61K 31/343
A61K 31/47
A61K 31/4704
A61K 9/00
Abstract:
The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.

Possible Relatives

David G Nowak  Dean R Nowak  Deborah D Nowak  Dana T Nowak  Aaron J Nowak  Denise G Nowak  Danielle N Nowak  Elizabeth A Last  Elizabeth L Johnson  Elizabeth R Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.